Lenvima
Lenvatinib
- Strength
- 4 mg/1
- Form
- Capsule
- Class
- Kinase Inhibitor
Eisai Inc.
Lenvima
Lenvatinib
Listed by Eisai Inc.
- Strength
- 10 mg/1
- Form
- Capsule
- Route
- Oral
- Class
- Kinase Inhibitor
What it contains
- Lenvatinib 10 mg/1
FDA record
| Dosage form | Capsule |
|---|---|
| Route | Oral |
| Drug class | Kinase Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 62856-710 |
| FDA application | NDA206947 |
| RxNorm concept | 1604345 |
| Package sizes listed | 1 |
| Marketed since | February 2015 |
Other products containing Lenvatinib
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.